Literature summary for 2.7.7.48 extracted from

Babadaei, M.M.N.; Hasan, A.; Vahdani, Y.; Bloukh, S.H.; Sharifi, M.; Kachooei, E.; Haghighat, S.; Falahati, M.
Development of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase (2020), J. Biomol. Struct. Dyn., 2020, 1-9 .

Search for more literature for 2.7.7.48

Inhibitors

Inhibitors	Comment	Organism	Structure
remdesivir	-	Severe acute respiratory syndrome coronavirus 2

Natural Substrates/ Products (Substrates)

Natural Substrates	Organism	Comment (Nat. Sub.)	Natural Products	Comment (Nat. Pro.)	Rev.	Reac.
nucleoside triphosphate + RNAn	Severe acute respiratory syndrome coronavirus 2	-	diphosphate + RNAn+1	-	?

Organism

Organism	UniProt	Comment	Textmining
Severe acute respiratory syndrome coronavirus 2	P0DTD1	replicase polyprotein 1ab; SARS-CoV-2	-

Substrates and Products (Substrate)

Substrates	Comment Substrates	Organism	Products	Comment (Products)	Rev.	Reac.
nucleoside triphosphate + RNAn	-	Severe acute respiratory syndrome coronavirus 2	diphosphate + RNAn+1	-	?

Synonyms

Synonyms	Comment	Organism
RDRP	-	Severe acute respiratory syndrome coronavirus 2
RNA-dependent RNA polymerase	-	Severe acute respiratory syndrome coronavirus 2

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)